From the Editor-in-Chief
Strategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
Cancer Today's Winter 2015/2016 issue describes advances in lung cancer, big data and more.
by Kevin McLaughlin
Should the Age to Buy Cigarettes Be 21? | Reducing Re-excision | Coming Out About Cancer | The Oncology Nurse Will See You Now | Uterine Cancer Rates on the Rise | Cancer Immunotherapies Continue to Make Headway
Your Cancer Guide
Live for today, but plan for tomorrow and beyond.
by Hester Hill Schnipper
Caregiving With Confidence
Make time for yourself so you can be strong for your loved ones.
by Marc Silver
Big data, using high-powered computers to gather and analyze massive amounts of patient information, promises to revolutionize cancer care. But experts say patient concerns about privacy and other issues must be addressed.
by Stephen Ornes
During her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
Yesterday & Today
Literary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
While much of the Western world was tightening restrictions on smoking, one European nation, the Netherlands, found itself embroiled in a political struggle between individual freedoms and public health.
by Cynthia Ryan
Coming to terms with feelings and emotions about weight gain and weight loss is often part of a cancer patient's experience.
Fuel Up With a Smoothie | Get Your Move On
Author Judith Kelman describes how cancer patients benefit from writing about their personal stories.
by Betty Russell
Staying healthy with a compromised immune system, dealing with a second cancer diagnosis, and determining if treatment side effects are normal or not.
Cindy's Legacy provides financial support to families who are affected by cancer.
by Eileen Glanton Loftus
Jared Levinthall, Carol Dellinger, Anne Ha.
Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
Identifying patients whose cancers will have durable responses to checkpoint inhibitors can guide treatment.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
Bladder cancer is the sixth most prevalent cancer in the United States and has a high rate of recurrence.
Handle With Care
donate to the AACR